Works matching IS 07414234 AND DT 2021 AND VI 41 AND IP 4
Results: 5
Eculizumab for Refractory Myasthenia Gravis.
- Published in:
- Neurology Alert, 2021, v. 41, n. 4, p. 1
- Publication type:
- Article
Infections Before Age 20 Years Increase the Risk of Multiple Sclerosis.
- Published in:
- Neurology Alert, 2021, v. 41, n. 4, p. 1
- Publication type:
- Article
Gene and Substrate Therapy for Neurogenetic Disease: A Combined Approach to Treat Mitochondrial Myopathy.
- Published in:
- Neurology Alert, 2021, v. 41, n. 4, p. 1
- Publication type:
- Article
TSPO PET Imaging for Monitoring Natalizumab-Associated Progressive Multifocal Leukoencephalopathy.
- Published in:
- Neurology Alert, 2021, v. 41, n. 4, p. 1
- Publication type:
- Article
Incidence, Prevalence, and Long-Term Consequences of Small Fiber Neuropathy.
- Published in:
- Neurology Alert, 2021, v. 41, n. 4, p. 1
- Publication type:
- Article